Reducing off-target drug accumulation by exploiting a type-III interferon response.
Tilden SG, Ricco MH, Hemann EA, Anchordoquy TJ. Reducing off-target drug accumulation by exploiting a type-III interferon response. J Control Release. 2023 06; 358:729-738.